Adults aged 60 or older who took high monthly doses of Vitamin D for 5 years failed to show a significant drop in risk for cardiovascular (CV) events in general but may have benefited for other CV outcomes in an analysis from a large prospective randomized trial.
Risk reductions on vitamin D in the mixed primary- and secondary-prevention population were slight in absolute terms but reached a significant 19% in the case of myocardial infarction (MI).
 
 
  
  
     
  
  
     
  
  
     
  
  
     
    
       
    
       
    
       
    
       
    
       
    
       
       
      
     
       
      





